The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Regulatory Updates on Compounded Peptides New Drug Loft and VLS Pharmacy When will the FDA reclassify BPC 157 to Category 1 Octagon AI Report: FDA Set to Unban RFK Jr.'s Favorite Peptides Peptides in 2026, What the FDA Review Means Olympia Pharmaceuticals FDA Peptide Reclassification 2026: What Researchers Want